Double vs Single Intrauterine Insemination in Male Factor Infertility

Sponsor
Umraniye Education and Research Hospital (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05885516
Collaborator
(none)
264
2
12.4

Study Details

Study Description

Brief Summary

The aim of the study is to compare the pregnancy outcomes of single vs double intrauterine insemination (IUI) in couples with male factor infertility.

Condition or Disease Intervention/Treatment Phase
  • Procedure: intrauterine insemination
N/A

Detailed Description

The principle behind double intrauterine insemination in male factor infertility couples is to create a longer time frame for fertilization and to increase motile sperm number in female genital tract in order to increase pregnancy rates. There's a clinical equipoise on the benefits of performing double IUI in couples following ovarian hyperstimulation with daily follicle stimulating hormone injections in male factor subfertility. As it is stated in Cochrane database, there's a need for adequately powered, randomized, high-quality studies on this subject.

In this study, as a result of a-priori power analysis 132 participants in each study arm is planned to be recruited in the study. Male factor infertility included in the study is defined as total motile sperm count (TPMSC) less than 10 million. TPMSC less than 1 million, female age greater than 40, uterine anomaly, no patent tubes shown in hysterosalpingography, history of ovarian surgery and known endometriosis will be excluded. Couples with two basal semen analysis with TPMSC between 1-10 million will be randomized to single or double IUI procedure. To accomplish this in approximately 1 year period, the study is planned as a multi-center study.

The objective of the study is to compare the pregnancy outcomes of single and double intrauterine insemination groups, following ovarian hyperstimulation in couples with male factor subfertility.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
264 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Care Provider, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Double vs Single Intrauterine Insemination in Male Factor Infertility - a Multicenter Randomized Trial
Anticipated Study Start Date :
Jun 5, 2023
Anticipated Primary Completion Date :
May 22, 2024
Anticipated Study Completion Date :
Jun 15, 2024

Arms and Interventions

Arm Intervention/Treatment
Placebo Comparator: Single intrauterine insemination group

When the leading follicle is greater than 17 mm following ovulation induction with follicle stimulating hormone (FSH) daily injections, ovulation trigger injection will be given to the participant. 36 hours after ovulation trigger injection single intrauterine insemination with partner's sperm collected on the same day will be done.

Procedure: intrauterine insemination
Giving washed sperm concentrate into uterine cavity via a soft catheter

Experimental: Double intrauterine insemination group

When the leading follicle is greater than 17 mm following ovulation induction with follicle stimulating hormone (FSH) daily injections, ovulation trigger injection will be given to the participant. 24 and 48 hours after ovulation trigger injection intrauterine insemination will be done twice with partner's sperm collected on the specified days.

Procedure: intrauterine insemination
Giving washed sperm concentrate into uterine cavity via a soft catheter

Outcome Measures

Primary Outcome Measures

  1. Rate of clinical pregnancy [Within 4-6 weeks after insemination]

    Pregnancy with fetal cardiac activity diagnosed by transvaginal ultrasonography

Secondary Outcome Measures

  1. Rate of biochemical, ectopic pregnancies and rate of miscarriages [Within 3 months after insemination]

    Pregnancy outcomes including biochemical, ectopic pregnancies and miscarriages diagnosed by transvaginal ultrasonography

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 40 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Couples trying to conceive for at least 6 months despite of regular sexual intercourse

  • Female partner between 18-40 years old

  • Male partner sperm analysis total motile sperm count between 1-10 million in at least 2 sperm analysis on different days.

Exclusion Criteria:
  • No patent fallopian tubes shown in hystero-salpingography

  • Female partner with a uterine anomaly

  • History of a previous ovarian surgery

  • Known or suspected endometriosis in female partner

  • Body-mass index (BMI) > 40 kg/m2

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Umraniye Education and Research Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Merve Dizdar, Principal Investigator, Umraniye Education and Research Hospital
ClinicalTrials.gov Identifier:
NCT05885516
Other Study ID Numbers:
  • B.10.1.TKH.4.34.H.GP.0.01/384
First Posted:
Jun 2, 2023
Last Update Posted:
Jun 2, 2023
Last Verified:
May 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 2, 2023